Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT ID: NCT07190495
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
102 participants
INTERVENTIONAL
2025-07-05
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
NCT05529004
The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting
NCT03626441
Metoclopramide-Ondansetron vs. Metoclopramide Therapy for Treatment of Nausea and Vomiting Post Laparoscopic Surgery
NCT03459248
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
NCT01733212
Oral Dexamethasone for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT06288035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ginger group
Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy
Ginger
Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy
Placebo group
Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy
Placebo
Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginger
Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy
Placebo
Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
* American Society of Anesthesiologists (ASA) physical status I-III.
* Able to understand the study procedures and provide written informed consent.
Exclusion Criteria
* Documented history of bleeding disorders or current treatment with anticoagulant agents
* History of severe postoperative nausea and vomiting or an Apfel score of 4
* Administration of antiemetic drugs or corticosteroids during the preoperative period
* Pregnancy or breastfeeding
* Active gastrointestinal or liver disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Tunis El Manar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Taleb Ibtissem
Assistant Professor in Anesthesiology and Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed Taher Maamouri University Hospital
Nabeul, Nabeul Governorate, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GINGER PONV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.